SCM
IMGN

Silverarc Capital Management’s Immunogen Inc IMGN Stock Holding History

Silverarc Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,307,435
Closed -$20.7M – 93
2023
Q3 		$20.7M Sell
1,307,435
-112,565
-8% -$1.87M 6.29% 2
2023
Q2 		$26.8M Buy
1,420,000
+1,270,000
+847% +$15M 8.29% 1
2023
Q1 		$576K Sell
150,000
-257,269
-63% -$1.1M 0.24% 63
2022
Q4 		$2.02M Sell
407,269
-31,426
-7% -$170K 0.58% 53
2022
Q3 		$2.1M Buy
438,695
+22,216
+5% +$117K 0.71% 46
2022
Q2 		$1.87M Sell
416,479
-228,521
-35% -$993K 0.58% 44
2022
Q1 		$3.07M Sell
645,000
-869,411
-57% -$4.81M 1.27% 19
2021
Q4 		$11.2M Buy
1,514,411
+864,492
+133% +$5.37M 4.55% 2
2021
Q3 		$3.69M Sell
649,919
-177,668
-21% -$1.03M 2.08% 16
2021
Q2 		$5.45M Buy
827,587
+98,223
+13% +$685K 2.43% 10
2021
Q1 		$5.91M Buy
729,364
+129,364
+22% +$1.06M 3.22% 6
2020
Q4 		$3.87M Buy
+600,000
New +$3.5M 2.25% 16

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silverarc Capital Management's IMGN Position: Q4 2023 in Review

Silverarc Capital Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 1,307,435 shares — an estimated $20.7M sold.

Silverarc Capital Management first reported a position in IMGN in Q4 2020 and held it in 12 quarters. The position peaked at $26.8M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Silverarc Capital Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 1,307,435 Immunogen Inc shares in Q4 2023, an estimated $20.7M.
  • Silverarc Capital Management first reported a position in Immunogen Inc in Q4 2020 and held it in 12 quarters.
  • Silverarc Capital Management's Immunogen Inc position peaked at $26.8M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Silverarc Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.